Butyrylcholinesterase anticorps (FITC)
Aperçu rapide pour Butyrylcholinesterase anticorps (FITC) (ABIN723028)
Antigène
Voir toutes Butyrylcholinesterase (BCHE) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Réactivité croisée
- Humain
-
Purification
- Purified by Protein G.
-
Immunogène
- Full length native protein purified from human
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IF(IHC-P) 1:50-200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- Butyrylcholinesterase (BCHE)
-
Autre désignation
- BCHE
-
Sujet
-
Synonyms: Cholinesterase, Acylcholine acylhydrolase, Choline esterase II, CHE1, Butyrylcholine esterase, Pseudocholinesterase, butyrylcholinesterase.CHLE_HUMAN.
Background: Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage. [provided by RefSeq, Jul 2008].
-
ID gène
- 590
-
Pathways
- Peptide Hormone Metabolism
Antigène
-